ENvue Medical, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-688.0K | $-588.0K | $-813.0K | $-727.0K | $-1.1M | $-1.1M | $-2.1M | $-955.0K |
| Depreciation & Amortization | — | — | $0 | $0 | $0 | $1.0K | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $0 | $107.0K | $124.0K | $36.0K | $66.0K | $67.0K | $67.0K | $-19.0K |
| Net Cash from Operating Activities | $-553.0K | $-579.0K | $-491.0K | $-682.0K | $-1.2M | $-1.2M | $-1.3M | $-2.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.0K | $1.0K | $0 | $0 | $0 | $1.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-2.0K | $-1.0K | $0 | $0 | $0 | $-1.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $0 | $4.2M | $0 | $7.0K | — | — |
| Net Change in Cash | $-530.0K | $-583.0K | $-504.0K | $3.5M | $-1.2M | $-1.2M | $741.0K | $-2.0M |
| Free Cash Flow | $-555.0K | $-580.0K | $-491.0K | $-682.0K | $-1.2M | $-1.2M | — | — |